Plöchl E
Padiatr Padol. 1978;13(2):123-36.
According to the two-mutation model of neuroblastoma several investigations were performed in order to find the gene carrier in a family with familial neuroblastoma. The results of these former studies are as follows: 1. Neither chromosomal analyses of the peripheral blood nor the examinations of catecholamines nor of cystathionine in the urine could mark the first step to neuroblastoma. 2. Since cystathioniuria was not only seen in blood-relations but also in relatives by marriage and since vitamin B6 deficiency was revealed, cystathioninuria was interpreted as secondary to vitamin B6 deficiency. In this study the normal values of cystathioninuria and vitamin B6 supply were examined. Furthermore the effect of oral vitamin B6 loading on cystathioninuria and oxaluria in familial neuroblastoma was investigated and the vitamin B6 supply in the neighbours of the family was analysed. The results permitted the following conclusions: 1. In 46 of 58 children and adults cystathioninuria was found in an immeasurable range by column chromatography. Only in 12 persons it could be measured quantitatively. With the exception of 6 explanable elevations no value exceeded 20 mumol/24 hr. These results show that the acceptance of the limiting value of 20 mumol/24 hr for increased cystathioninuria is justified. 2. Vitamine B6 deficiency was found in two of 7 patients. In one child this could be explained by the underlying disease. This finding supports the suggestion that vitamine B6 deficiency can relative frequently observed. 3. The examinations of cystathioninuria and oxaluria before and after loading with vitamine B6 showed different results. Whereas oxaluria decreased after loading cystathioninuria was not surely influenced. 4. The neighbours of the members with familial neuroblastoma showed mostly a reduced vitamine B6 supply. This fact could be an indication of exogenous reason of vitamine B6 deficiency in familial neuroblastoma.
根据神经母细胞瘤的双突变模型,开展了多项调查,以在一个患有家族性神经母细胞瘤的家庭中寻找基因携带者。这些先前研究的结果如下:1. 外周血的染色体分析、尿中儿茶酚胺及胱硫醚的检测均无法作为神经母细胞瘤的早期指标。2. 由于胱硫醚尿不仅见于血亲,也见于姻亲,且发现存在维生素B6缺乏,因此胱硫醚尿被认为是维生素B6缺乏的继发性表现。在本研究中,检测了胱硫醚尿和维生素B6供应的正常值。此外,研究了口服维生素B6负荷对家族性神经母细胞瘤患者胱硫醚尿和草酸尿的影响,并分析了该家族邻居的维生素B6供应情况。结果得出以下结论:1. 在58名儿童和成人中,通过柱色谱法在46人身上发现胱硫醚尿处于无法测量的范围。仅在12人身上可进行定量测量。除6例可解释的升高外,没有数值超过20 μmol/24小时。这些结果表明,将胱硫醚尿增加的限值设定为20 μmol/24小时是合理的。2. 在7名患者中有2人发现维生素B6缺乏。在一名儿童中,这可由基础疾病解释。这一发现支持了维生素B6缺乏相对常见的观点。3. 维生素B6负荷前后的胱硫醚尿和草酸尿检测结果不同。负荷后草酸尿减少,而胱硫醚尿未受到确切影响。4. 家族性神经母细胞瘤患者的邻居大多维生素B6供应减少。这一事实可能表明家族性神经母细胞瘤中维生素B6缺乏存在外部原因。